Health Condition 1: O- Medical and Surgical Health Condition 2: null- Tuberculosis patients-stable
Conditions
Interventions
Intervention1: Cholicalciferol Sachet 60000 IU (Vitamin D): Subjects in the active intervention arm receive a cholecalciferol sachet orally (60, 000 IU D3/week for first 8 weeks and then monthly to co
Sponsors
Department of Health Research
Eligibility
Inclusion criteria
Inclusion criteria: Age �15 years Diagnosed PTB CAT I case as per RNTCP guidelines Able to give informed written consent Willing to participate in the study No major medical or surgical illness
Exclusion criteria
Exclusion criteria: Not willing to participate Age > 60 years With major medical or surgical illness Chronic Alcoholic Pregnancy &lactation, On vitamin D and calcium supplementation On any other drug affecting bone mineral homeostasis during past six months, Any other clinically overt disease Body mass index (BMI) Seriously ill patients requiring hospitalization
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the effect of vitamin D3 supplementation in the prevention of relapse in category1 (CAT1) treated pulmonary Tuberculosis patientTimepoint: 6 months, 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of TB relapse will be done in patients at the end to study periodTimepoint: 3 yrs | — |
Countries
India
Contacts
Public ContactDr Himanshu Thukral
AIIMS
Outcome results
None listed